Form 4: Paychex Director Kara Wilson Reports Stock and Option Transactions
SEC Form 4
Director Kara Wilson reported the acquisition of 761 shares of common stock and 3,351 stock options in Paychex Inc.
Summary
- Kara Wilson, a director at Paychex Inc. (PAYX), filed a Form 4 detailing changes in beneficial ownership.
- On July 15, 2024, Wilson acquired 761 shares of common stock at $0 and 3,351 stock options with an exercise price of $121.63.
- Following the reported transaction, Wilson directly owns 7,365 shares of Paychex common stock.
- Wilson also holds multiple stock options with varying exercise prices and expiration dates.
- These options include 9,615 options exercisable from July 13, 2018, at $57.2, 8,641 options exercisable from July 12, 2019, at $70.37, and other tranches exercisable annually through July 15, 2024.
- The reported transactions were executed pursuant to the Amended and Restated 2002 Stock Incentive Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating stock and option acquisitions by a director, which could be interpreted as a positive sign of confidence, but it's not definitively bullish.
Positives
- The acquisition of stock and options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may view the director's stock and option acquisitions as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 07/13/2018 | Date from which 9,615 stock options are exercisable at $57.2, expiring 07/12/2027 |
| 07/12/2019 | Date from which 8,641 stock options are exercisable at $70.37, expiring 07/11/2028 |
| 07/11/2020 | Date from which 7,929 stock options are exercisable at $85.33, expiring 07/10/2029 |
| 07/15/2021 | Date from which 5,793 stock options are exercisable at $73.53, expiring 07/14/2030 |
| 07/15/2022 | Date from which 5,075 stock options are exercisable at $112.67, expiring 07/14/2031 |
| 07/15/2023 | Date from which 3,027 stock options are exercisable at $115, expiring 07/14/2032 |
| 07/15/2024 | Date of transaction: acquisition of 761 shares of common stock and 3,351 stock options; Date from which 3,382 stock options are exercisable at $120.86, expiring 07/14/2033 |
| 07/17/2024 | Date of signature by Stephanie L. Schaeffer, Attorney-in-fact |
| 07/14/2034 | Expiration date of 3,351 stock options acquired on 07/15/2024 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.